GenAI-driven healthcare insurance claims and risk management startup Consint.AI raises Rs 5 crore in funding

GenAI-driven healthcare Insurance fraud and risk management startup Consint.AI has raised Rs 5 crore in a seed funding round led by Equanimity Ventures and Seafund. 

The startup plans to use the raised capital to scale operations through expanded sales outreach and accelerate the development of the Generative AI Feature Suite for the Health AI Platform.

This includes enhancing fraud detection, optimizing claims processing, and delivering personalized clinical care to drive innovation in healthcare.

Additionally, the funding will also support team expansion, infrastructure upgrades, and R&D efforts to strengthen its position as a leader in the health tech solutions market.

What does Consint.AI do?

Founded in 2020 by Ashish Chaturvedi and later joined by Swadeep Singh as Co-Founder, Consint.AI is a pioneering Generative AI-driven healthcare fraud and risk management company dedicated to transforming healthcare transactions and personalized care.

The startup aims to optimize healthcare claims transactions, making it affordable and efficient with its cutting-edge platforms like Risk.ai, engineered to optimize insurance transactions and mitigate fraud, and CIPHR.ai which is designed to enhance critical patient management and streamline claims generation.

By harnessing advanced Generative AI solutions, it empowers businesses across emerging markets and the U.S. to drive value-based care, operational efficiency, and sustainable growth.

Consint.AI's market presence

In the last 12 months, Consint.AI has achieved remarkable traction, expanding into India, the Middle East, and Africa. The startup has recently launched CIPHR.ai, an AI-driven platform tailored for hospitals, built upon custom Generative AI models to revolutionize care personalization in critical patient management.

CIPHR.ai provides intelligence at point of care and generates claims transactions enhancing efficiency for healthcare providers. Targeted at emerging health markets and the U.S. Accountable Care Organization (ACO) sector, this platform leverages Generative AI to address the evolving needs of modern healthcare systems.

In the last two quarters, the startup claims to have secured Rs 10 crore in signed contracts, including multiple multi-year agreements with leading insurance providers and hospital systems, highlighting strong market validation and growing demand for its innovative solutions, particularly in the areas of Generative AI and Document Forensics.

Leadership comments

Ashish Chaturvedi, Founder and CEO of Consint, said, "This current market traction and milestones highlight the transformative potential of Generative AI in reshaping healthcare as we know it. At Consint, we are pioneering GenAI-driven platforms like CIPHR.ai and Risk.ai to solve complex challenges in healthcare transactions and personalized care. Our focus remains on advancing our Generative AI capabilities to drive innovation, deliver impactful solutions, and empower businesses globally to achieve seamless operations and value-based care. This funding accelerates our mission to lead the charge in AI-powered healthcare transformation."

Manoj Agarwal, Managing Partner, Seafund, said, “Our focus on emerging tech like GenAI, deep tech, IoT and sustainability has been the guiding force when it comes to backing unique and innovative startups. Consent.AI’s laser sharp focus on solving the problem of healthcare Insurance claims processing and fraud detection improving performance of Insurance and Healthcare institutions is a multi-billion dollar problem to solve and we believe that we have the necessary expertise and network to help the company grow and reach its ambitions.”